Cargando…
The prevalence of diabetes and thyroid related autoantibodies in Sri Lankan children with type 1 diabetes and their unaffected siblings – The utility of a new screening assay
BACKGROUND: There is limited information about diabetes and thyroid related autoantibodies in children with type 1 diabetes (T1D) or their siblings in Sri Lanka. OBJECTIVES: To assess in T1D children and their unaffected siblings the prevalence of autoantibodies to (1) glutamic acid decarboxylase (G...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939822/ https://www.ncbi.nlm.nih.gov/pubmed/36814577 http://dx.doi.org/10.3389/fendo.2023.1028285 |
_version_ | 1784890945321304064 |
---|---|
author | Atapattu, Navoda Amoroso, Marie Powell, Michael de Silva, D. G. Harendra de Silva, K. Shamya H. Furmaniak, Jadwiga Rees Smith, Bernard Premawardhana, Lakdasa D. |
author_facet | Atapattu, Navoda Amoroso, Marie Powell, Michael de Silva, D. G. Harendra de Silva, K. Shamya H. Furmaniak, Jadwiga Rees Smith, Bernard Premawardhana, Lakdasa D. |
author_sort | Atapattu, Navoda |
collection | PubMed |
description | BACKGROUND: There is limited information about diabetes and thyroid related autoantibodies in children with type 1 diabetes (T1D) or their siblings in Sri Lanka. OBJECTIVES: To assess in T1D children and their unaffected siblings the prevalence of autoantibodies to (1) glutamic acid decarboxylase (GADA), insulinoma associated antigen-2 (IA-2A) and zinc transporter 8 (ZnT8A) using 3 Screen ICA™ (3-Screen) and individual ELISA assays; (2) insulin (IAA); and (3) thyroid peroxidase (TPOA), thyroglobulin (TgA) and the TSH receptor (TSHRA). METHODS: We selected - (a) consecutive T1D children, and (b) their unaffected siblings of both sexes, from the T1D Registry at Lady Ridgeway Hospital, Colombo. RESULTS: The median age (IQR) of 235 T1D children and 252 unaffected siblings was 11 (8.4, 13.2) and 9 (5.4, 14.9) years respectively, and the duration of T1D was 23 (7, 54) months. (1) T1D children (a) 79.1% were 3-Screen positive; (b) all 3-Screen positives were individual antibody positive (GADA in 74%; IA-2A 31.1%; ZnT8A 38.7%); (c) and were younger (p=0.01 vs 3-Screen negatives); (d) multiple autoantibodies were present in 45.1%; (e) IA-2A (p=0.002) and ZnT8A (p=0.006) prevalence decreased with T1D duration. (f) TPOA and TgA prevalence was higher in T1D children compared to unaffected siblings (28%, p=0.001 and 31%, p=0.004, respectively). (2) Unaffected siblings (a) 6.3% were 3-Screen positive (p=0.001 vs T1D), and 2.4% were positive for IAA; (b) four subjects had two diabetes related autoantibodies, one of whom developed dysglycaemia during follow-up. CONCLUSIONS: The 3-Screen assay, used for the first time in Sri Lankan T1D children and their siblings as a screening tool, shows a high prevalence of T1D related Abs with a high correlation with individual assays, and is also a helpful tool in screening unaffected siblings for future T1D risk. The higher prevalence of thyroid autoantibodies in T1D children is consistent with polyglandular autoimmunity. |
format | Online Article Text |
id | pubmed-9939822 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-99398222023-02-21 The prevalence of diabetes and thyroid related autoantibodies in Sri Lankan children with type 1 diabetes and their unaffected siblings – The utility of a new screening assay Atapattu, Navoda Amoroso, Marie Powell, Michael de Silva, D. G. Harendra de Silva, K. Shamya H. Furmaniak, Jadwiga Rees Smith, Bernard Premawardhana, Lakdasa D. Front Endocrinol (Lausanne) Endocrinology BACKGROUND: There is limited information about diabetes and thyroid related autoantibodies in children with type 1 diabetes (T1D) or their siblings in Sri Lanka. OBJECTIVES: To assess in T1D children and their unaffected siblings the prevalence of autoantibodies to (1) glutamic acid decarboxylase (GADA), insulinoma associated antigen-2 (IA-2A) and zinc transporter 8 (ZnT8A) using 3 Screen ICA™ (3-Screen) and individual ELISA assays; (2) insulin (IAA); and (3) thyroid peroxidase (TPOA), thyroglobulin (TgA) and the TSH receptor (TSHRA). METHODS: We selected - (a) consecutive T1D children, and (b) their unaffected siblings of both sexes, from the T1D Registry at Lady Ridgeway Hospital, Colombo. RESULTS: The median age (IQR) of 235 T1D children and 252 unaffected siblings was 11 (8.4, 13.2) and 9 (5.4, 14.9) years respectively, and the duration of T1D was 23 (7, 54) months. (1) T1D children (a) 79.1% were 3-Screen positive; (b) all 3-Screen positives were individual antibody positive (GADA in 74%; IA-2A 31.1%; ZnT8A 38.7%); (c) and were younger (p=0.01 vs 3-Screen negatives); (d) multiple autoantibodies were present in 45.1%; (e) IA-2A (p=0.002) and ZnT8A (p=0.006) prevalence decreased with T1D duration. (f) TPOA and TgA prevalence was higher in T1D children compared to unaffected siblings (28%, p=0.001 and 31%, p=0.004, respectively). (2) Unaffected siblings (a) 6.3% were 3-Screen positive (p=0.001 vs T1D), and 2.4% were positive for IAA; (b) four subjects had two diabetes related autoantibodies, one of whom developed dysglycaemia during follow-up. CONCLUSIONS: The 3-Screen assay, used for the first time in Sri Lankan T1D children and their siblings as a screening tool, shows a high prevalence of T1D related Abs with a high correlation with individual assays, and is also a helpful tool in screening unaffected siblings for future T1D risk. The higher prevalence of thyroid autoantibodies in T1D children is consistent with polyglandular autoimmunity. Frontiers Media S.A. 2023-02-06 /pmc/articles/PMC9939822/ /pubmed/36814577 http://dx.doi.org/10.3389/fendo.2023.1028285 Text en Copyright © 2023 Atapattu, Amoroso, Powell, de Silva, de Silva, Furmaniak, Rees Smith and Premawardhana https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Endocrinology Atapattu, Navoda Amoroso, Marie Powell, Michael de Silva, D. G. Harendra de Silva, K. Shamya H. Furmaniak, Jadwiga Rees Smith, Bernard Premawardhana, Lakdasa D. The prevalence of diabetes and thyroid related autoantibodies in Sri Lankan children with type 1 diabetes and their unaffected siblings – The utility of a new screening assay |
title | The prevalence of diabetes and thyroid related autoantibodies in Sri Lankan children with type 1 diabetes and their unaffected siblings – The utility of a new screening assay |
title_full | The prevalence of diabetes and thyroid related autoantibodies in Sri Lankan children with type 1 diabetes and their unaffected siblings – The utility of a new screening assay |
title_fullStr | The prevalence of diabetes and thyroid related autoantibodies in Sri Lankan children with type 1 diabetes and their unaffected siblings – The utility of a new screening assay |
title_full_unstemmed | The prevalence of diabetes and thyroid related autoantibodies in Sri Lankan children with type 1 diabetes and their unaffected siblings – The utility of a new screening assay |
title_short | The prevalence of diabetes and thyroid related autoantibodies in Sri Lankan children with type 1 diabetes and their unaffected siblings – The utility of a new screening assay |
title_sort | prevalence of diabetes and thyroid related autoantibodies in sri lankan children with type 1 diabetes and their unaffected siblings – the utility of a new screening assay |
topic | Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939822/ https://www.ncbi.nlm.nih.gov/pubmed/36814577 http://dx.doi.org/10.3389/fendo.2023.1028285 |
work_keys_str_mv | AT atapattunavoda theprevalenceofdiabetesandthyroidrelatedautoantibodiesinsrilankanchildrenwithtype1diabetesandtheirunaffectedsiblingstheutilityofanewscreeningassay AT amorosomarie theprevalenceofdiabetesandthyroidrelatedautoantibodiesinsrilankanchildrenwithtype1diabetesandtheirunaffectedsiblingstheutilityofanewscreeningassay AT powellmichael theprevalenceofdiabetesandthyroidrelatedautoantibodiesinsrilankanchildrenwithtype1diabetesandtheirunaffectedsiblingstheutilityofanewscreeningassay AT desilvadgharendra theprevalenceofdiabetesandthyroidrelatedautoantibodiesinsrilankanchildrenwithtype1diabetesandtheirunaffectedsiblingstheutilityofanewscreeningassay AT desilvakshamyah theprevalenceofdiabetesandthyroidrelatedautoantibodiesinsrilankanchildrenwithtype1diabetesandtheirunaffectedsiblingstheutilityofanewscreeningassay AT furmaniakjadwiga theprevalenceofdiabetesandthyroidrelatedautoantibodiesinsrilankanchildrenwithtype1diabetesandtheirunaffectedsiblingstheutilityofanewscreeningassay AT reessmithbernard theprevalenceofdiabetesandthyroidrelatedautoantibodiesinsrilankanchildrenwithtype1diabetesandtheirunaffectedsiblingstheutilityofanewscreeningassay AT premawardhanalakdasad theprevalenceofdiabetesandthyroidrelatedautoantibodiesinsrilankanchildrenwithtype1diabetesandtheirunaffectedsiblingstheutilityofanewscreeningassay AT atapattunavoda prevalenceofdiabetesandthyroidrelatedautoantibodiesinsrilankanchildrenwithtype1diabetesandtheirunaffectedsiblingstheutilityofanewscreeningassay AT amorosomarie prevalenceofdiabetesandthyroidrelatedautoantibodiesinsrilankanchildrenwithtype1diabetesandtheirunaffectedsiblingstheutilityofanewscreeningassay AT powellmichael prevalenceofdiabetesandthyroidrelatedautoantibodiesinsrilankanchildrenwithtype1diabetesandtheirunaffectedsiblingstheutilityofanewscreeningassay AT desilvadgharendra prevalenceofdiabetesandthyroidrelatedautoantibodiesinsrilankanchildrenwithtype1diabetesandtheirunaffectedsiblingstheutilityofanewscreeningassay AT desilvakshamyah prevalenceofdiabetesandthyroidrelatedautoantibodiesinsrilankanchildrenwithtype1diabetesandtheirunaffectedsiblingstheutilityofanewscreeningassay AT furmaniakjadwiga prevalenceofdiabetesandthyroidrelatedautoantibodiesinsrilankanchildrenwithtype1diabetesandtheirunaffectedsiblingstheutilityofanewscreeningassay AT reessmithbernard prevalenceofdiabetesandthyroidrelatedautoantibodiesinsrilankanchildrenwithtype1diabetesandtheirunaffectedsiblingstheutilityofanewscreeningassay AT premawardhanalakdasad prevalenceofdiabetesandthyroidrelatedautoantibodiesinsrilankanchildrenwithtype1diabetesandtheirunaffectedsiblingstheutilityofanewscreeningassay |